Roberts et al showed that the plasma ACE2 activity seemed to have increased in all chronic kidney disease (CKD) groups including predialysis, transplant patients, and even dialysis patients when compared with the historical samples of healthy subjects. The gene discussed is ACE2; the disease is chronic kidney disease.